Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial

Clinical trial NCT06447415 · COMPLETED

Trial details

NCT number: NCT06447415
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2024-08-06
Primary completion: 2025-03-18
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.